M
Michael D. Blum
Researcher at Merck & Co.
Publications - 7
Citations - 767
Michael D. Blum is an academic researcher from Merck & Co.. The author has contributed to research in topics: Vaccination & Pneumococcal polysaccharide vaccine. The author has an hindex of 6, co-authored 6 publications receiving 651 citations.
Papers
More filters
Journal ArticleDOI
Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Jens U. Ruggeberg,Michael Gold,José-María Bayas,Michael D. Blum,Jan Bonhoeffer,Sheila Fallon Friedlander,Glacus de Souza Brito,Ulrich Heininger,Babatunde Imoukhuede,Ali Khamesipour,Michel Erlewyn-Lajeunesse,Susana Martin,Mika J. Mäkelä,Patricia Nell,Vitali Pool,Nicholas Simpson +15 more
TL;DR: The Brighton Collaboration Anaphylaxis Working Group aims to provide a platform for international co-operation and co-ordination in the furtherance of knowledge and understanding of anaphylactic shock.
Journal ArticleDOI
Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation.
S. Michael Marcy,Katrin S. Kohl,Ron Dagan,David R. Nalin,Michael D. Blum,Marcy Connell Jones,John Hansen,Jerry Labadie,Lucia Lee,Bryan Martin,Katherine L. O'Brien,Edward P. Rothstein,Patricia Vermeer +12 more
TL;DR: The Brighton Collaboration Fever Working Group’s findings have implications for the design and implementation of future vaccination campaigns in the U.S. and around the world.
Journal ArticleDOI
Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.
Daniel M. Musher,Susan B. Manoff,Charlie Liss,Richard D. McFetridge,Rocio D. Marchese,Bonnie Bushnell,Frances B. Alvarez,Carla Painter,Michael D. Blum,Jeffrey L. Silber +9 more
TL;DR: Both primary vaccination and revaccination with PN23 induce antibody responses that persist during 5 years of observation, and baseline geometric mean concentrations of IgG were higher in revaccinations than primary vaccination subjects.
Journal ArticleDOI
Fever after Immunization: Current Concepts and Improved Future Scientific Understanding
Katrin S. Kohl,S. Michael Marcy,Michael D. Blum,Marcy Connell Jones,Ron Dagan,John Hansen,David R. Nalin,Edward P. Rothstein +7 more
TL;DR: By standardizing the definition and means of assessment of fever in vaccine safety studies, thereby permitting comparability of data, it is hoped that an improved understanding of its importance as an AEFI is arrived at.
Journal ArticleDOI
A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers.
Michael D. Blum,Ron Dagan,Paul M. Mendelman,Vered Pinsk,Michael Giordani,Shu Li,Norman R. Bohidar,Tessie McNeely +7 more
TL;DR: A single dose of PCV at 12-18 months of age primed for responses to booster doses of either PCV or PN23 12 months later, resulting in more frequent injection site pain and erythema than boosting with PCV, yet higher antibody concentrations for most of the serotypes tested.